As part of its sustained and growing commitment to realize a more diverse, equitable, and inclusive future, ASHG has launched the Genetics and Genomics Impact Partnerships program this January to strengthen partnerships with like-minded organizations sharing these goals Illumina, a leader in next-generation genomic sequencing technologies, and Invitae, a leading medical genetics company, have joined... Read More
As an ASHG member you have access to countless career resources. No matter what career stage you are at, whether it be trainee, undergraduate, post-doc or a head of a lab, the Society has you covered. Over the past year, the Society has continued to find ways to invest in programs, resources, and tools to... Read More
As part of its continued investment and support of ASHG current and future members, the Society regularly seeks, values, and uses your input. Most recently, a major triennial membership survey in early January of 2022 shows continued strong support and value in the Society’s many programs and highlights potential new directions. Along with your participation... Read More
ASHG recently submitted a response to the NOT-OD-22-029 Request for Information (RFI) from the National Institutes of Health (NIH) pertaining to its Genomic Data Sharing Policy (GDS policy). The GDS policy regulates the expectations and procedures for researchers who generate genomic data as part of their NIH-funded research, as well as for researchers who wish to gain access... Read More
Posted by Evelyn Mantegani, Manager, Public Engagement, Communications and Marketing, ASHG Michael Bauer, PhD, is a member of the Public Education and Awareness Committee (PEAC) and is an Assistant Professor at the University of Arkansas for Medical Sciences in Little Rock, Arkansas. He is a bioinformatician who specializes in cancer genomics using Next Generation Sequencing... Read More
ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy